RMFCX | TRLCX | RMFCX / TRLCX | |
Total Expense Ratio | 0.91 | 0.66 | 138% |
Annual Report Gross Expense Ratio | 0.91 | 0.66 | 138% |
Fund Existence | 23 years | 23 years | - |
Gain YTD | 13.689 | 11.647 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 111B | 6.17B | 1,800% |
Annual Yield % from dividends | 1.20 | 1.13 | 107% |
Returns for 1 year | 4.96 | 4.84 | 102% |
Returns for 3 years | 38.79 | 35.30 | 110% |
Returns for 5 years | 57.10 | 53.74 | 106% |
Returns for 10 years | 91.18 | 53.02 | 172% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FACSX | 52.87 | 0.36 | +0.69% |
Nuveen Mid Cap Value Opportunities C | |||
TRIEX | 28.68 | 0.06 | +0.21% |
Nuveen International Eq Idx Retire | |||
FACTX | 53.84 | 0.05 | +0.09% |
Fidelity Advisor Health Care M | |||
DASVX | 15.17 | -0.02 | -0.13% |
Dunham Small Cap Value A | |||
BIEMX | 15.70 | -0.13 | -0.82% |
William Blair Emerging Mkts Growth R6 |